12
total announcements
524816.BO · 15 min delayed
Natco Pharma Ltd
Natco Pharma Ltd announced an investor meet on August 24, 26, and 27, 2026, in Singapore, organized by Nuvama Wealth Management and ICICI Securities Limited. The company's officials will participate in the meeting to discuss the latest investor presentation, available on the company's website.
Natco Pharma Ltd
Natco Pharma Ltd has made an investor presentation, which is a general background information about the company's activities as of the date of the presentation.
Natco Pharma Ltd
Natco Pharma Ltd's Q1 FY27 earnings conference call transcript is available on the company's website, discussing financial highlights, including a decline in consolidated total revenues and an improvement in EBITDA margin.
Natco Pharma Ltd
Natco Pharma Ltd has announced an investor meeting organized by Nuvama Wealth Management Limited and ICICI Securities Limited on August 19th and 21st, 2026, in Mumbai. The meeting is not intended to discuss unpublished price sensitive information.
Natco Pharma Ltd
Natco Pharma Ltd has published un-audited financial results for Q1 FY 2026-27 and declared an interim dividend. The results and dividend declaration were published in newspapers on August 15, 2026, and are available on the company's website.
Natco Pharma Ltd
Natco Pharma Ltd has announced the weblink of the audio transcript for its Q1FY2026-27 earnings call held on August 14, 2026.
Natco Pharma Ltd
Natco Pharma Ltd has released its Q1FY27 Earnings Presentation, providing general background information about the company's activities as of the date of the presentation.
Natco Pharma Ltd
Natco Pharma Ltd has declared an interim dividend of Rs.1.50 (75%) per equity share of Rs.2/- each for the financial year 2026-27. The record date is fixed as Thursday, 20th August 2026, and the payment will start from 26th August 2026.
Natco Pharma Ltd
Natco Pharma Ltd announced unaudited financial results for Q1 FY27, with consolidated revenue of ₹794.4 Crore and profit after tax of ₹206.5 Crore. The company declared an interim dividend of ₹1.5 per equity share. The Board also approved the reconstitution of Risk Management Committee and Environment, Social and Governance Committee.
Natco Pharma Ltd
Natco Pharma Ltd will host an earnings call with investors and analysts on August 14, 2026, to discuss its un-audited financial results for the quarter ended June 30, 2026.
Natco Pharma Ltd
Natco Pharma Ltd has informed BSE that the company's Board of Directors will meet on August 14, 2026 to consider raising funds through various methods, including public issue, preferential issue, rights issue, and private placement.
Natco Pharma Ltd
Natco Pharma Ltd has scheduled a board meeting on August 14, 2026, to consider un-audited financial results for the quarter ended June 30, 2026, and to declare an interim dividend, if any.